Abbott Laboratories (ABT)

Investing Cash Flow

-$22.37B

TTM · Period ending: · USD

ABT logo

ABT Investing Cash Flow

Latest reported-$22.37B
ABT TTM Cash from Investing (-$618.30M → -$22.37B)
High-resolution chart · PNG

ABT investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Abbott Laboratories Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-7,469,667,000
-6,132,499,000
-617,664,000
-805,788,000
-1,174,637,000
-1,166,247,000
-1,198,249,000
-1,119,581,000
-918,724,000
-1,337,040,000
-1,420,866,000
-1,346,927,000
-1,463,810,000
-1,216,134,000
-1,197,671,000
-1,314,301,000
-1,256,601,000
-1,944,724,000
-1,955,241,000
-1,758,234,000
-1,763,699,000
-850,933,000
-1,037,723,000
-1,034,906,000
-1,061,196,000
-1,114,923,000
-944,085,000
-853,337,000
-763,167,000
-780,125,000
-793,838,000
-956,200,000
-999,800,000
-664,700,000
-667,600,000
-653,400,000
-586,100,000
-885,900,000
-642,100,000
-410,300,000
-398,700,000
-430,600,000
-618,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.